Celsius (NASDAQ:CELH) PT Lowered to $47.00 at Piper Sandler

Celsius (NASDAQ:CELH) had its target price decreased by Piper Sandler from $50.00 to $47.00 in a research report sent to investors on Tuesday morning, Benzinga reports. Piper Sandler currently has an overweight rating on the stock.

CELH has been the subject of a number of other reports. UBS Group decreased their target price on Celsius from $70.00 to $64.00 and set a buy rating for the company in a research report on Wednesday, August 7th. B. Riley decreased their price objective on Celsius from $80.00 to $73.00 and set a buy rating for the company in a report on Wednesday, August 7th. BNP Paribas initiated coverage on shares of Celsius in a report on Monday, June 24th. They set an outperform rating and a $87.00 price objective on the stock. Bank of America reduced their target price on shares of Celsius from $32.00 to $26.00 and set an underperform rating for the company in a research note on Thursday, September 5th. Finally, Maxim Group lowered their price target on shares of Celsius from $65.00 to $50.00 and set a buy rating on the stock in a research report on Thursday, September 5th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of Moderate Buy and an average target price of $57.43.

Celsius Stock Performance

Shares of NASDAQ:CELH opened at $31.32 on Tuesday. Celsius has a fifty-two week low of $30.86 and a fifty-two week high of $99.62. The company’s 50-day moving average is $39.17 and its 200 day moving average is $62.58. The company has a market capitalization of $7.30 billion, a P/E ratio of 34.42, a price-to-earnings-growth ratio of 2.45 and a beta of 1.85.

Celsius (NASDAQ:CELH) last released its earnings results on Tuesday, August 6th. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.05. Celsius had a net margin of 19.58% and a return on equity of 94.75%. The firm had revenue of $402.00 million during the quarter, compared to the consensus estimate of $391.07 million. During the same period in the prior year, the firm earned $0.17 EPS. The company’s revenue was up 23.4% compared to the same quarter last year. As a group, research analysts predict that Celsius will post 0.82 earnings per share for the current year.

Insider Transactions at Celsius

In related news, CEO John Fieldly sold 74,847 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $32.80, for a total value of $2,454,981.60. Following the sale, the chief executive officer now directly owns 1,812,490 shares of the company’s stock, valued at $59,449,672. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.20% of the stock is owned by insiders.

Institutional Trading of Celsius

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Transcendent Capital Group LLC bought a new position in Celsius in the fourth quarter valued at $25,000. FinTrust Capital Advisors LLC bought a new position in shares of Celsius during the 1st quarter valued at about $25,000. Heritage Wealth Advisors raised its holdings in shares of Celsius by 200.0% during the 4th quarter. Heritage Wealth Advisors now owns 552 shares of the company’s stock valued at $30,000 after buying an additional 368 shares in the last quarter. S.A. Mason LLC bought a new stake in Celsius in the 2nd quarter worth approximately $30,000. Finally, EverSource Wealth Advisors LLC boosted its stake in Celsius by 3,116.7% in the first quarter. EverSource Wealth Advisors LLC now owns 386 shares of the company’s stock worth $32,000 after buying an additional 374 shares in the last quarter. Hedge funds and other institutional investors own 60.95% of the company’s stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.